Expression of HOXA10 and HOXA11 in the Endometrium of Infertility Patients With an Endometrial Polyp Before and After Polypectomy
NCT ID: NCT02761278
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2016-07-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endometrial and Myometrial Changes, With and Without Fibroids
NCT01671215
Ultrasound and Endometrial Hyperplasia
NCT00123188
Hysteroscopy in Chronic Anovulation
NCT03545945
Mid-Infrared Spectroscopy as a Real Time Diagnostic Tool for Chronic Endometritis
NCT04197167
Endometrial Biopsy in Infertile Patients
NCT00064935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HOXA10 and HOXA11 Expression Before Polypectomy
A biopsy will taken in infertility patients with endometrial polyp before polypectomy
Endometrial biopsy
HOXA10 and HOXA11 Expression After Polypectomy
A biopsy will taken in infertility patients with endometrial polyp 1-3 months after polypectomy
Endometrial biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endometrial biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Polycystic ovary syndrome
* Hydrosalpinx
* Sub-mucus myoma
* Women who have taken hormonal therapy in the preceding month
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guy Shrem, MD
Role: PRINCIPAL_INVESTIGATOR
Hillel Yaffe Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYMC-0039-16
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.